NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints CEO Robert Eno to Board of Directors
HeartBeam (NASDAQ: BEAT) a medical technology company advancing personalized cardiac care, has appointed Chief Executive Officer Robert Eno to its Board of Directors, expanding the board from eight to nine members. Eno, who joined the company as president in January 2023 and became CEO in October 2024, brings over 30 years of medtech leadership experience, including launching disruptive technologies. His appointment comes as the company prepares for the commercial launch of its 3D ECG technology, pending FDA clearance of its 12-lead ECG synthesis software. To view the full press release, visit https://nnw.fm/k1vzD About HeartBeam Inc. HeartBeam is a medical technology…







